Hickson LaTonya J, Chaudhary Sanjay, Williams Amy W, Dillon John J, Norby Suzanne M, Gregoire James R, Albright Robert C, McCarthy James T, Thorsteinsdottir Bjorg, Rule Andrew D
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic College of Medicine, Rochester, MN.
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN.
Am J Kidney Dis. 2015 Apr;65(4):592-602. doi: 10.1053/j.ajkd.2014.10.015. Epub 2014 Nov 5.
Recent policy clarifications by the Centers for Medicare & Medicaid Services have changed access to outpatient dialysis care at end-stage renal disease (ESRD) facilities for individuals with acute kidney injury in the United States. Tools to predict "ESRD" and "acute" status in terms of kidney function recovery among patients who previously initiated dialysis therapy in the hospital could help inform patient management decisions.
Historical cohort study.
SETTING & PARTICIPANTS: Incident hemodialysis patients in the Mayo Clinic Health System who initiated in-hospital renal replacement therapy (RRT) and continued outpatient dialysis following hospital dismissal (2006 through 2009).
Baseline estimated glomerular filtration rate (eGFR), acute tubular necrosis from sepsis or surgery, heart failure, intensive care unit, and dialysis access.
Kidney function recovery defined as sufficient kidney function for outpatient hemodialysis therapy discontinuation.
Cohort consisted of 281 patients with a mean age of 64 years, 63% men, 45% with heart failure, and baseline eGFR≥30mL/min/1.73m(2) in 46%. During a median of 8 months, 52 (19%) recovered, most (94%) within 6 months. Higher baseline eGFR (HR per 10-mL/min/1.73m(2) increase eGFR, 1.27; 95% CI, 1.16-1.39; P<0.001), acute tubular necrosis from sepsis or surgery (HR, 3.34; 95% CI, 1.83-6.24; P<0.001), and heart failure (HR, 0.40; 95% CI, 0.19-0.78, P=0.007) were independent predictors of recovery within 6 months, whereas first RRT in the intensive care unit and catheter dialysis access were not. There was a positive interaction between absence of heart failure and eGFR≥30mL/min/1.73m(2) for predicting kidney function recovery (P<0.001).
Sample size.
Kidney function recovery in the outpatient hemodialysis unit following in-hospital RRT initiation is not rare. As expected, higher baseline eGFR is an important determinant of recovery. However, patients with heart failure are less likely to recover even with a higher baseline eGFR. Consideration of these factors at hospital discharge informs decisions on ESRD status designation and long-term hemodialysis care.
美国医疗保险和医疗补助服务中心最近的政策澄清改变了终末期肾病(ESRD)设施中急性肾损伤患者获得门诊透析治疗的情况。对于那些之前在医院开始透析治疗的患者,预测其肾功能恢复方面的“ESRD”和“急性”状态的工具有助于为患者管理决策提供信息。
历史性队列研究。
梅奥诊所医疗系统中开始住院肾脏替代治疗(RRT)并在出院后继续门诊透析的新发血液透析患者(2006年至2009年)。
基线估计肾小球滤过率(eGFR)、败血症或手术引起的急性肾小管坏死、心力衰竭、重症监护病房和透析通路。
肾功能恢复定义为肾功能足以停止门诊血液透析治疗。
队列包括281名患者,平均年龄64岁,63%为男性,45%患有心力衰竭,46%的患者基线eGFR≥30mL/min/1.73m²。在中位8个月期间,52名(19%)患者恢复,大多数(94%)在6个月内恢复。基线eGFR每增加10mL/min/1.73m²(HR,1.27;95%CI,1.16 - 1.39;P<0.001)、败血症或手术引起的急性肾小管坏死(HR,3.34;95%CI,1.83 - 6.24;P<0.001)和心力衰竭(HR,0.40;95%CI,0.19 - 0.78,P = 0.007)是6个月内恢复的独立预测因素,而在重症监护病房首次进行RRT和导管透析通路则不是。在预测肾功能恢复方面,无心力衰竭与eGFR≥30mL/min/1.73m²之间存在正相互作用(P<0.001)。
样本量。
住院开始RRT后门诊血液透析单元中的肾功能恢复并不罕见。正如预期的那样,较高的基线eGFR是恢复的重要决定因素。然而,即使基线eGFR较高,心力衰竭患者恢复的可能性也较小。出院时考虑这些因素有助于就ESRD状态指定和长期血液透析护理做出决策。